Germany · Delayed Price · Currency is EUR AlzChem Group AG Statistics
Total Valuation
ETR:ACT has a market cap or net worth of EUR 1.65 billion. The enterprise value is 1.68 billion.
| Market Cap | 1.65B |
| Enterprise Value | 1.68B |
Important Dates
The next confirmed earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | May 6, 2026 |
Share Statistics
ETR:ACT has 10.12 million shares outstanding. The number of shares has decreased by -0.25% in one year.
| Current Share Class | 10.12M |
| Shares Outstanding | 10.12M |
| Shares Change (YoY) | -0.25% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 15.48% |
| Owned by Institutions (%) | 39.77% |
| Float | 5.40M |
Valuation Ratios
The trailing PE ratio is 24.36 and the forward PE ratio is 23.38. ETR:ACT's PEG ratio is 1.69.
| PE Ratio | 24.36 |
| Forward PE | 23.38 |
| PS Ratio | 2.78 |
| PB Ratio | 6.08 |
| P/TBV Ratio | 6.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.18 |
| PEG Ratio | 1.69 |
Enterprise Valuation
| EV / Earnings | 24.77 |
| EV / Sales | 2.83 |
| EV / EBITDA | 13.98 |
| EV / EBIT | 18.01 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.33.
| Current Ratio | 2.70 |
| Quick Ratio | 1.74 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 0.75 |
| Debt / FCF | -4.09 |
| Interest Coverage | 44.77 |
Financial Efficiency
Return on equity (ROE) is 27.66% and return on invested capital (ROIC) is 26.89%.
| Return on Equity (ROE) | 27.66% |
| Return on Assets (ROA) | 9.50% |
| Return on Invested Capital (ROIC) | 26.89% |
| Return on Capital Employed (ROCE) | 16.64% |
| Weighted Average Cost of Capital (WACC) | 6.15% |
| Revenue Per Employee | 353,455 |
| Profits Per Employee | 40,341 |
| Employee Count | 1,794 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 1.80 |
Taxes
In the past 12 months, ETR:ACT has paid 25.67 million in taxes.
| Income Tax | 25.67M |
| Effective Tax Rate | 27.42% |
Stock Price Statistics
The stock price has increased by +15.91% in the last 52 weeks. The beta is 0.39, so ETR:ACT's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +15.91% |
| 50-Day Moving Average | 166.06 |
| 200-Day Moving Average | 162.98 |
| Relative Strength Index (RSI) | 49.46 |
| Average Volume (20 Days) | 20,933 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:ACT had revenue of EUR 593.80 million and earned 67.77 million in profits. Earnings per share was 6.70.
| Revenue | 593.80M |
| Gross Profit | 389.71M |
| Operating Income | 93.21M |
| Pretax Income | 93.62M |
| Net Income | 67.77M |
| EBITDA | 118.13M |
| EBIT | 93.21M |
| Earnings Per Share (EPS) | 6.70 |
Balance Sheet
The company has 65.70 million in cash and 90.22 million in debt, with a net cash position of -24.53 million or -2.42 per share.
| Cash & Cash Equivalents | 65.70M |
| Total Debt | 90.22M |
| Net Cash | -24.53M |
| Net Cash Per Share | -2.42 |
| Equity (Book Value) | 271.92M |
| Book Value Per Share | 26.66 |
| Working Capital | 194.30M |
Cash Flow
In the last 12 months, operating cash flow was 116.48 million and capital expenditures -138.56 million, giving a free cash flow of -22.08 million.
| Operating Cash Flow | 116.48M |
| Capital Expenditures | -138.56M |
| Depreciation & Amortization | 24.92M |
| Net Borrowing | 41.75M |
| Free Cash Flow | -22.08M |
| FCF Per Share | -2.18 |
Margins
Gross margin is 65.63%, with operating and profit margins of 15.70% and 11.41%.
| Gross Margin | 65.63% |
| Operating Margin | 15.70% |
| Pretax Margin | 15.77% |
| Profit Margin | 11.41% |
| EBITDA Margin | 19.89% |
| EBIT Margin | 15.70% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 1.29%.
| Dividend Per Share | 2.10 |
| Dividend Yield | 1.29% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 31.37% |
| Buyback Yield | 0.25% |
| Shareholder Yield | 1.54% |
| Earnings Yield | 4.10% |
| FCF Yield | -1.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ETR:ACT is 205.81, which is 26.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 205.81 |
| Price Target Difference | 26.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 11.75% |
| EPS Growth Forecast (3Y) | 18.71% |
Stock Splits
The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 1, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ETR:ACT has an Altman Z-Score of 4.55 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.55 |
| Piotroski F-Score | 5 |